Early clinical and programmatic outcomes with tenofovir-based antiretroviral therapy in Zambia

BACKGROUND: In July 2007, amid some controversy over cost, Zambia was the first African country to introduce tenofovir (TDF) as a component of first-line antiretroviral therapy (ART) on a wide scale. METHODS: We compared drug substitutions, mortality, and “programmatic failure” among adults starting...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Chi, Benjamin H., Mwango, Albert, Giganti, Mark, Mulenga, Lloyd B., Tambatamba-Chapula, Bushimbwa, Reid, Stewart E., Bolton-Moore, Carolyn, Chintu, Namwinga, Mulenga, Priscilla L., Stringer, Elizabeth M., Sheneberger, Robert, Mwaba, Peter, Stringer, Jeffrey S. A.
Format: Artigo
Idioma:Inglês
Publicat: 2010
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2862003/
https://ncbi.nlm.nih.gov/pubmed/20009765
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/QAI.0b013e3181c6c65c
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars